In the present investigation, the polygenic FATZO mouse model of obesity and type 2 diabetes with an intact leptin pathway diet developed progressive NAFLD/NASH similar to humans when fed with WDF. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.